Adicet Bio Stock
Adicet Bio, Inc.
Company data
- Sector
- Healthcare
- Industry
- Biotechnology
- Country
- United States
- CEO
- Chen Schor
- Employees
- 102
- Market cap
- $43 M
- IPO
- 26/01/2018
Adicet Bio, Inc. is a biotechnology firm dedicated to pioneering allogeneic gamma delta T cell therapies, aiming to treat cancer and various other diseases. The company’s strategy involves engineering gamma delta T cells with chimeric antigen receptors (CARs) and T cell receptor-like antibodies. This advanced…
Adicet Bio stock: price history
1D
-11.1%
1W
-18.5%
1M
-49.5%
6M
-44.4%
YTD
-45.7%
1Y
-72.5%
2Y
-80.8%
5Y
-96.4%
10Y
–
Next earnings date
Next earnings date
04/11/2026 (in 18 days)
Volatility around earnings
~16% weaker price swings than usual
Ask the agents about Adicet Bio
Analyst assessment of Adicet Bio
PRICE TARGET LOW
US$27.00
CONSENSUS
US$27.00
MEDIAN
US$27.00
PRICE TARGET HIGH
US$27.00
0
STRONG BUY
9
BUY
3
HOLD
0
SELL
0
STRONG SELL
12
TOTAL · Buy
As of: 29/09/2026
Adicet Bio stock metrics
P/E
-0.4
P/B
0.41
EV/EBITDA
-0.24
RETURN ON EQUITY
-17.8%
NET MARGIN
0.0%
DEBT/EQUITY
0.11
DIVIDEND YIELD
0.0%
AS OF
30/06/2026
Free float & liquidity
FREE FLOAT
87.8%
FLOAT SHARES
8,217,235
AVG. DAILY VOLUME (30D)
288,692
Insider transactions (SEC)
RA CAPITAL MANAGEMENT, L.P.
Institutional holders
Dividends & Stock splits
Dividends
Stock splits
Comparable stocks
Frequently asked questions about Adicet Bio stock
What does Adicet Bio do?
Adicet Bio, Inc. is a company in the Healthcare sector, Biotechnology industry, headquartered in United States.
The CEO is Chen Schor, the company employs around 102 people.
The IPO was on 26/01/2018; the stock trades on NASDAQ under the ticker ACET.
What do analysts say about Adicet Bio stock?
12 analysts rate the stock, the consensus is Buy (as of 29/09/2026).
The average price target is US$27.00, ranging from US$27.00 to US$27.00, with a median of US$27.00.
This is an external assessment, not a statement by Market Jury.
When does Adicet Bio report next?
The next earnings date is 04/11/2026.
Around past earnings, price swings were roughly -16% stronger than usual.
Does Adicet Bio pay a dividend?
Yes. The last dividend was US$0.00 per share, ex-date 21/09/2018, paid on 09/10/2018.
The dividend yield is 0.0% (as of 30/06/2026).
Which stocks are comparable to Adicet Bio?
Comparable stocks include Vertex Pharmaceuticals, Moderna, Regeneron Pharmaceuticals, Revolution Medicines, Incyte, Exelixis, Neurocrine Biosciences and Summit Therapeutics.
How can I get Adicet Bio stock analyzed?
Clicking "Analyze stock" lets five strategies assess Adicet Bio against fixed, published rules and judge it bullish, neutral or bearish. The jury states where it disagrees. A free account starts with 5 credits, a quick check costs 1 credit, a full analysis 2 credits.
Not investment advice. Past performance is not an indicator of future results.